Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia
Clinical trial NCT01658956 · UNKNOWN
Trial details
- NCT number
- NCT01658956
- Sponsor
- Jules Bordet Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.